RBC
MRNA icon

Roble Belko & Company’s Moderna MRNA Stock Holding History

Roble Belko & Company’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-150
Closed -$27K – 315
2022
Q4 		$27K Buy
+150
New +$27K 0.01% 191